GLA:D provided remotely
During this time of managing COVID 19, rehabilitation clinics across Canada are closed and unable to provide face to face treatment to their patients. With the requirement to socially isolate many people are restricted in their ability to be physically active and are suffering from their symptoms related to their hip and knee osteoarthritis.
The GLA:D® program is an education and exercise program which promotes independence in physical activity. For many people the program can be completed independently at home with supervision and direction from a qualified therapist. As such many of the GLA:D trained clinicians are now providing the program remotely through visual technology, working with their patients through smart phones, tablets or laptops.
For anyone who is interested in participating in a remote program we have provided some information here to help you decide if it is for you. If you decide you want to participate you should contact your local clinic to see if they are providing the program remotely, or contact the GLA:D™ Canada national team at email@example.com and we will help you to identify a suitable clinic location.
GLA:D™ Canada are pleased to announce the release of GLA:D Annual Report for 2018. The report “Implementation and outcomes” provides the data analysed from participants who went through the program up to the end of 2018.
- 20 courses have been provided to train health care professionals
- 760 clinicians have been trained of which 74% are physiotherapists
- 154 sites have launched in 7 provinces
- a mean 26% improvement in pain
- over 30% of individuals experiencing a marked improvement in activities of daily living and sports and recreation
- over 40% of individuals experiencing a marked improvement in quality of life
This supplementary report presents provincial-level patient registry data for the three highest-enrolling provinces to the end of 2018: Ontario, Alberta and British Columbia. Data for the remaining provinces and territories have been excluded because of limited patient numbers and/or lack of 12 month follow up data to the end of 2018.
GLA:D® is an evidence-based program for treatment and management of osteoarthritic symptoms. GLA:D™ Canada is licensed to the Canadian Orthopaedic Foundation. It is currently being implemented by Bone and Joint Canada, a knowledge translation division of the Canadian Orthopaedic Foundation.